Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model-Reference-Cited by-同舟云学术

Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model

Published:2018-12 Issue:8 Volume:18 Page:928-934
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Peters Mary Linton B^ORCID,Eckel Andrew,Mueller Peter P.,Tramontano Angela C.,Weaver Davis T.,Lietz Anna,Hur Chin,Kong Chung Yin,Pandharipande Pari V.

Funder

American Cancer Society - New England Division - Ellison Foundation Research Scholar

National Cancer Institute

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference36 articles.

1. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma;Andea;Mod Pathol Offic J United States Can Acad Pathol,2003

2. Current understanding of precursors to pancreatic cancer;Takaori;J Hepato-Biliary-Pancreatic Surg,2007

3. Pancreatic intraepithelial neoplasia;Takaori;Pancreas,2004

4. The prevalence and clinicopathological characteristics of high-grade pancreatic intraepithelial neoplasia: autopsy study evaluating the entire pancreatic parenchyma;Matsuda;Pancreas,2017

5. Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance?;Konstantinidis;Ann Surg Oncol,2013

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics profiling to identify early plasma biomarkers in pre-diagnostic pancreatic ductal adenocarcinoma: a nested case-control study;Translational Oncology;2024-10

2. Precision therapy for cancer prevention by targeting carcinogenesis;Molecular Carcinogenesis;2024-08-14

3. Biomarkers in Cancer Screening;Hematology/Oncology Clinics of North America;2024-08

4. Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy;Cancers;2024-05-09

5. Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer;Familial Cancer;2024-04-15